Vaccination centers in Europe are standing ready — but no vaccine is available. Pfizer has cut its production, and AstraZeneca has announced it would be delivering 60% less than agreed with the EU.
This article is part of a series of explainers on vaccine development and distribution. Learn more about vaccines – from how they work and how they’re made to ensuring safety and equitable access – in WHO’s Vaccines Explained series.